[管理超级华法林中毒:一个具有挑战性的案例]
Giovanna Zavadzki1, José Inzunza Robles2, María Fernanda San Martín3
1Hospital Dr Sótero del Río, Fundación Epistemonikos, Universidad Federal de Sao Paulo, Brasil.
概括
超级华法林是强大的杀剂,会导致难以控制的出血. 这一案例表明,由于维生素K的半衰期长,需要长时间的维生素K治疗和密切监测.
科学领域:
- 毒理学 毒理学 毒理学
- 内部医学 内部医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 超级华法林是长期作用的抗凝固剂杀虫剂.
- Intoxication 可以导致严重的凝血病.
- 对超华法林中毒的管理是具有挑战性的.
研究的目的:
- 介绍一个自杀企图后人类超级华法林中毒的案例.
- 为了说明超华法林中毒的临床过程和管理策略.
主要方法:
- 一个42岁的男性患者的病例报告,他摄入了一剂有毒的杀鼠剂.
- 凝血参数 (INR) 的连续监测.
- 在七天的住院期间优化维生素K补充剂.
主要成果:
- 患者呈现出表和明显升高的INR11.6.
- 治疗包括七天的连续凝血测试和调整的维生素K剂量.
- 该案例突出显示了抗凝剂的效力和延长的半衰期 (大约2个月). 6周) 的时间.
结论:
- 超级华法林杀虫剂中毒需要警的临床观察和管理.
- 长时间的维生素K治疗对于有效治疗至关重要.
- 由于作用的持续时间长,患者坚持治疗至关重要.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
681
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
681
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Esophageal Varices-II: Clinical Features and Management
60
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
60
Prevention of Further Absorption of Poison
817
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
817
Anticholinesterase Agents: Poisoning and Treatment
848
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
848
Therapeutic Index
4.2K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.2K


